Physiotherapy for Children with CLN2 Disease
AUTOR(ES)
Löbbecke, Ina von
FONTE
J. inborn errors metab. screen.
DATA DE PUBLICAÇÃO
04/11/2019
RESUMO
Abstract CLN2 disease (neuronal ceroid lipofuscinosis type 2) is a rare, genetic, paediatric-onset, neurodegenerative lysosomal storage disorder characterised by seizures, ataxia, rapid loss of motor function and language ability, dementia, visual loss and early death. Physiotherapy plays an important role in the management of CLN2 disease, aiming to maintain the best possible functioning and autonomy of the child, support the child’s participation in everyday life, limit secondary complications and maintain or improve quality of life. This article discusses the physiotherapeutic treatment of children diagnosed with CLN2 disease. Based on the author’s clinical experience, frequent muscular impairments associated with CLN2 disease, their impact on affected children’s sensorimotor abilities and autonomy, and physiotherapy interventions are described. Common muscular deficits included abnormal muscle tone leading to poor trunk control, difficulty standing upright, often accompanied by equinus contractures and movement disorders such as myoclonus. The use of orthotic and adaptive medical devices that support an erect posture in locomotion and positioning appear to be particularly beneficial for prolonging sensorimotor control, communication and food intake. In conclusion, early initiation of physiotherapy is recommended and should include the provision of adaptive walking, standing, sitting and positioning aids.
Documentos Relacionados
- An Adapted Clinical Measurement Tool for the Key Symptoms of CLN2 Disease
- Neuronal Ceroid Lipofuscinoses Are Connected at Molecular Level: Interaction of CLN5 Protein with CLN2 and CLN3
- Nucleotide sequence of the Saccharomyces cerevisiae CLN1 and CLN2 genes.
- FUS3 represses CLN1 and CLN2 and in concert with KSS1 promotes signal transduction.
- Activation of CLN1 and CLN2 G1 cyclin gene expression by BCK2.